Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05901259 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes

Study acronym: EXOREG
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Sponsor changed: Exoneural Network AB to Otto Bock Healthcare Products GmbHv5
  2. Trial status: Not Yet Recruiting to Recruitingv4 Show 7 more changesShow less
    • Start date changed from estimate of Aug 1, 2024 to Feb 18, 2026
    • Interventions: Exopulse Mollii Suit (Device) to EXOPULSE Mollii Suit and EXOPULSE Suit (Device)
    • Eligibility criteria expanded, about 13 words
    • Secondary endpoints: 8 to 9
    • Study description expanded, about 9 words
    • Study site revised
    • Study title shortened, about 2 words
  3. Study title revisedv3
  4. Start date: Aug 1, 2023 to Aug 1, 2024v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective is to explore the potential short and long-term impact of the EXOPULSE Mollii Suit and EXOPULSE Suit on subjects with CP, MS, stroke, fibromyalgia or other neurologic disorders which may cause such types of symptoms, and to identify high responders among the sub-categories of the diagnoses. The primary endpoint will be improvements in the Berg/Pediatric Balance Scale (BBS/PBS) as a measurement of balance and risk of falls.
Trial Details
NCT Number NCT05901259
Lead Sponsor Otto Bock Healthcare Products GmbH
Conditions
(from sponsor)		 Cerebral Palsy, Multiple Sclerosis, Stroke, Neurologic Disorder, Fibromyalgia
Related terms Cerebral Palsy, Fibromyalgia, Multiple Sclerosis, Nervous System Diseases, Stroke
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov